Mary Jane Raymond
Analyst · Dave Kang with B. Riley. Your line is now open
Thanks Chuck. In Chuck’s comments today we focused on the market trends. I will turn your attention to page 3 of the press release table 2, where you can find the results by segment, including bookings, revenue, operating income and the operating margin. Our bookings were $244.3 million, our revenue was $221.5 million, our reported EPS was $0.26 a share, and if we exclude the $0.09 per share of the investment that Chuck just discussed, the adjusted EPS was $0.35 a share. Of the trends Chuck discussed, you will see the influence of the growth in the communications end market in the photonics and performance products bookings growing in total 60% and 12% respectively compared to Q1 of last year. This is also evident in the photonics revenue, which grew 33% over the same quarter last year and attained a similar record-breaking level of revenue to that achieved in Q4 of FY16 just last quarter. Our organic growth in the quarter was nearly all in photonics. 3% of our year-over-year consolidated growth was due to acquisitions or just under $6 million and this was all in the laser solutions segment. During this quarter, the industrial market remained strong but changed in its percentage of our revenue to 32%, while the strength in the communications end market drove its share of our revenue to 43%. 10% was the military and 15% was in other end markets. Regionally, 45% of our sales were to North America, 19% were to China, 16% to the rest of Asia and 20% to Europe. Our gross margin of 39.5% advanced 110 basis points sequentially. About 70 basis points of this was due to the receipt of insurance proceeds for last year’s Q1 FY16 flood in Fuzhou, China. Our book-to-bill ratio was 1.1 for Q1, our backlog was $311 million consisting of $76 million in laser solutions, $123 million in photonics, and $112 million in performance products. We have solid order for the upcoming quarter. Our R&D spending this quarter was $21.8 million or 10% of revenue. While this is a similar dollar level to that achieved in the fourth quarter, it is a very different composition and it is considerably higher than a year ago or 15% higher all due to the VCSEL platform investment. During the fourth quarter, we still had quite a bit of R&D and engineering that was associated with the RF products business that we sold in June. The R&D for the RF products also was either sold or reduced. With that transaction complete in the first quarter of this year the company commenced its announced investment program for VCSELs for 3D sensing about $25 million pre-tax for FY17. The Q1 portion was $7.6 million, and just as a reminder VCSEL or V-C-S-E-L, stands for vertical cavity surface emitting lasers. The SG&A expenses in the quarter for Q1 2017 were down 3% sequentially compared to Q4 2016, but were up 16% compared to Q1 2017. While we are adding customer facing resources to drive the organic growth and we are continuing to evaluate select M&A opportunities, we are also investing in efforts to consolidate some of the SG&A spending around the world. During this period, we are carefully controlling additions to our expenses. The Q1 2017 tax rate was 31.7%. The tax rate was affected this quarter by an increase in our FIN 48 reserve. The reported EPS in the quarter was $0.26 a share, and includes the investment for the VCSEL platform of $0.09 a share. Our cash on hand is $220 million and our net debt position is $28 million. We had $30 million of cash outflow for capital expenditures this quarter. We still expect to commit a $100 million to $110 million in capital for FY17 driven by our new investments and capacity expansion, and we expect the cash flow in the year for capital to be a similar amount. We had $4.1 million in share-based compensation for the quarter. For FY17 we expect the share-based comp to be between $13 million to $15 million, higher than our normal $12 million to $14 million due to two factors. One is the increase in share price and the other one is the first time investing in a three-year performance [risk]. We did not purchase any shares here in this first quarter of FY17. We had $31 million remaining on our $50 million stock repurchase authorization. For fiscal year ’17 our excess cash is focused on funding our investment program and paying down our debt, though as always we will monitor our stock buyback opportunities. Turning to the outlook, the outlook for the second fiscal quarter ending December 31, 2016 is revenue of $220 million to $230 million and diluted earnings per share of $0.24 to $0.29. The increased R&D platform investment will remain about $0.10 a share for this quarter. This is all at prevailing exchange rates and all the earnings per share comments refer to diluted shares. Our diluted share count is now 63,590,000 shares, and the comparable results for the quarter ended December 31, 2015 with revenues of $191.4 million and diluted earnings per share of $0.30. As discussed in more detail during our Q&A, our actual results may differ from these forecasts due to a variety of factors, including but not limited to product demand, customer forecast, competition and the general economic condition. This concludes our prepared remarks. Before we open the line for questions, I will just let you know that our second quarter earnings release date is slated for Tuesday, January 24, 2017. So as a reminder, all the comments we make including the forward-looking statements are just based on our knowledge today. And with that Chelsea, you may open the line for questions.